Published in Nouv Presse Med on October 20, 1973
Jaundice due to carbimazole. Gut (1975) 1.00
Carbimazole-induced jaundice. J R Soc Med (1985) 0.75
Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr (1992) 1.67
Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest (1982) 1.50
Systemic but not renal production of prostacyclin is highly reduced in cyclosporin-treated heart transplant recipients. Am J Cardiol (1993) 1.39
A simple and efficient method for platelet isolation from their plasma. Thromb Res (1980) 1.26
Pseudomembranous colitis probably due to rifampicin. Lancet (1980) 1.22
Rapid purification and partial characterization of human platelet glycoprotein IIIb. Interaction with thrombospondin and its role in platelet aggregation. J Biol Chem (1989) 1.18
Glycoproteins of platelet membranes from Glanzmann's thrombasthenia. A comparison with normal using carbohydrate-specific or protein-specific labelling techniques and high-resolution two-dimensional gel electrophoresis. Eur J Biochem (1981) 1.13
Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. Stroke (1998) 1.08
Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients. Haemostasis (1975) 1.06
One-step procedure for the rapid isolation of mouse monoclonal antibodies and their antigen binding fragments by fast protein liquid chromatography on a mono Q anion-exchange column. J Chromatogr (1985) 1.03
Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus. Thromb Res (1980) 0.99
Monoclonal antibodies against platelet membrane glycoproteins. Characterization and effect on platelet function. Eur J Biochem (1983) 0.99
The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0. Blood Coagul Fibrinolysis (1998) 0.97
Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. Arthritis Rheum (1998) 0.96
Complex formation of human thrombospondin with osteonectin. Eur J Biochem (1988) 0.96
Thrombocytopenia, macrothrombocytopathia, nephritis and deafness. Am J Med (1976) 0.95
[Polyneuritis due to lindane]. J Med Lyon (1969) 0.90
Identification of human platelet glycoproteins in SDS-polyacrylamide gels using 125I labelled lectins. Thromb Res (1979) 0.90
Isolation of thrombospondin released from thrombin-stimulated human platelets by fast protein liquid chromatography on an anion-exchange Mono-Q column. J Chromatogr (1984) 0.89
Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. Thromb Res (1984) 0.89
Role of lipoxygenase products in platelet function: relation to fatty acid modified phospholipids. Adv Exp Med Biol (1985) 0.88
Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors. J Thorac Cardiovasc Surg (1993) 0.87
Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. Thromb Res (1988) 0.86
Protein-S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts. Endocrinology (1992) 0.86
A comparison of the major platelet membrane glycoproteins from Bernard-Soulier syndrome with normals after radiolabelling of sialic acid or terminal galactose/N-acetylgalactosamine residues. Thromb Res (1980) 0.86
Studies on platelet glycoproteins in Glanzmann's thrombasthenia using 125I-labelled lectins. Br J Haematol (1980) 0.86
Antiprothrombinase and factor II deficiency in a non SLE patient. Thromb Haemost (1981) 0.86
[Spontaneous and bilateral fracture of the base of the 5th metatarsus: fracture due to faigue]. Arch Mal Prof (1970) 0.86
Population pharmacokinetics of recombinant factor VIIa in volunteers anticoagulated with acenocoumarol. Thromb Haemost (1998) 0.86
[Accidents caused by tetrahydrofuran (Quincke's edema and lipothymic attacks)]. Rev Med Suisse Romande (1968) 0.84
Description of 10 new mutations in platelet glycoprotein IIb (alphaIIb) and glycoprotein IIIa (beta3) genes. Platelets (2001) 0.84
Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke. Correlations of outcome with clinical and radiological data. Stroke (1996) 0.84
Lipoxygenase activity of intact human platelets. Prostaglandins Leukot Med (1984) 0.83
Platelet membrane glycoprotein abnormalities in patients with myeloproliferative disorders and secondary thrombocytosis. Br J Haematol (1985) 0.83
Identification of two distinct regions within the binding sites for fibrinogen and fibronectin on the IIb-IIIa human platelet membrane glycoprotein complex by monoclonal antibodies P2 and P4. Eur J Biochem (1986) 0.82
Two novel fibrinogen variants found in patients with pulmonary embolism and their families. J Thromb Haemost (2003) 0.81
Prostaglandin E2-like activity of 20:3n-9 platelet lipoxygenase end-product. FEBS Lett (1985) 0.81
Inhibition of thrombin-induced platelet arachidonic acid release by 15-hydroperoxy-arachidonic acid. Biochem Biophys Res Commun (1981) 0.81
Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oral prostacyclin derivative: a study in healthy male subjects. Can J Physiol Pharmacol (1996) 0.81
Polyunsaturated fatty acids: drug or food? World Rev Nutr Diet (1984) 0.81
Comparative evaluation of plasma thrombospondin beta-thromboglobulin and platelet factor 4 in acute myocardial infarction. Thromb Res (1985) 0.81
Constitutional thrombocytopathy with subnormal response to thromboxane A2. Br J Haematol (1981) 0.81
Antithrombin III deficiency during continuous venovenous hemodialysis. Contrib Nephrol (1995) 0.80
Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase. Br J Haematol (1978) 0.80
[A 3d case of hepatitis caused by cyclofenil in Lyons]. Gastroenterol Clin Biol (1986) 0.80
[Unknown benzene exposures. Their systematic detection during severe hemopathies, (Survey of 200 hospitalized hemopathic patients)]. Arch Mal Prof (1968) 0.79
In vitro incorporation and metabolism of some icosaenoic acids in platelets. Effect on arachidonic acid oxygenation. Biochim Biophys Acta (1985) 0.79
Osteonectin is an alpha-granule component involved with thrombospondin in platelet aggregation. J Bone Miner Res (1991) 0.79
Thalamic stroke and congenital factor V deficiency. Stroke (1991) 0.79
Expression of adhesion molecules in endothelial cells during allogeneic bone marrow transplantation. Eur J Haematol (1994) 0.79
[Benzene hydrocarbons and severe hemopathies]. Arch Mal Prof (1970) 0.79
A comparison of techniques used to study externally oriented proteins and glycoproteins of human blood platelets. Thromb Res (1979) 0.79
Tryptic peptide map analysis of the major human blood platelet membrane glycoproteins separated by two-dimensional polyacrylamide gel electrophoresis. Biochim Biophys Acta (1982) 0.79
Nicergoline, an anti-aggregating agent which inhibits release of arachidonic acid from human platelet phospholipids. Prostaglandins (1980) 0.79
Platelet phospholipid in stroke. Clin Chim Acta (1978) 0.79
[Fibrinolytic activity of platelets]. Nouv Presse Med (1973) 0.78
Effects of ticlopidine on platelet prostaglandin metabolism. Possible consequences for prostacyclin production. Prostaglandins Med (1979) 0.78
[Malignant hemopathies and benzolism]. Med Lav (1972) 0.78
Increased thrombosis incidence in a family with an inherited protein S deficiency and a high oxygen affinity hemoglobin variant. Am J Hematol (1994) 0.78
[Comments on indemnifiction for benzene-induced leukemia and aplasia (apropos of 48 cases)]. Arch Mal Prof (1971) 0.78
Human plasma fibrinogen measurement derived from activated partial thromboplastin time clot formation. Blood Coagul Fibrinolysis (2002) 0.78
[Severe viral hepatitis. Intravascular coagulation and fibrinolysis. Radioisotopic study of the life of platelets and fibrinogens]. Presse Med (1971) 0.78
Illegitimate transcription: its use for studying genetic abnormalities in lymphoblastoid cells from patients with Glanzmann thrombasthenia. Br J Haematol (1998) 0.78
Aggregation to thrombin and collagen of platelets from a Glanzmann thrombasthenic patient lacking glycoproteins IIb and IIIa. Thromb Haemost (1989) 0.78
Identification of new and known polymorphisms in glycoprotein IIb and IIIa genes by denaturing gradient gel electrophoresis. Platelets (1998) 0.78
Immunofluorescence study of mucosal B lymphocytes in bile reflux gastritis. Digestion (1979) 0.78
Tandem separation of labelled human blood platelet membrane glycoproteins by anion-exchange and gel fast protein liquid chromatography. J Chromatogr (1985) 0.78
Identification and characterization of fragments of major glycoproteins from platelet membrane after chymotrypsin treatment. Eur J Biochem (1985) 0.78
Decrease of platelet activity after intake of small amounts of eicosapentaenoic acid in diabetics. Thromb Haemost (1982) 0.78
Increase of platelet prostaglandin cyclic endoperoxides in thrombosis. Lancet (1977) 0.78
Factor IX gene analysis in 70 unrelated patients with haemophilia B: description of 13 new mutations. Thromb Haemost (1999) 0.78
[Duodenal tuberculosis: a difficult diagnosis]. Presse Med (1997) 0.77
Refractoriness of diabetic platelets to inhibitory prostaglandins. Prostaglandins Med (1981) 0.77
Occupational asthma after exposure to azodicarbonamide: report of four cases. Br J Ind Med (1989) 0.77
Human platelet PGE1 and dihomogammalinolenic acid. Comparison to PGE2 and arachidonic acid. Prog Lipid Res (1981) 0.77
Uptake and effect on arachidonic acid oxygenation of some icosaenoic acids in human platelets. Biomed Biochim Acta (1984) 0.77
[Unrecognized occupational risk of pleural mesothelioma. The example of the Rhône-Alps region]. Rev Mal Respir (1993) 0.77
Significant reduction in the binding of a monoclonal antibody (LYP 18) directed against the IIb/IIIa glycoprotein complex to platelets of patients having undergone extracorporeal circulation. Thromb Haemost (1987) 0.77
Simultaneous enzymo-immunologic assays of platelet associated IgG, IgM and C3. A useful tool in assessment of immune thrombocytopenias. Thromb Res (1982) 0.77
Thrombin decreases platelet cyclic AMP in the absence of prostaglandin synthesis. Biomedicine (1977) 0.77
[Alterations in hemostasis during treatment with sodium dipropylacetate (Depakine) (R)]. Pediatrie (1979) 0.77
Evaluation of coagulation equilibrium at baseline and during factor VIII and factor IX replacement in haemophiliacs. Blood Coagul Fibrinolysis (1998) 0.77
Fatty acid composition in native and cultured human endothelial cells. In Vitro (1984) 0.76
Metabolism of human monoclonal immunoglobulin D. A study in two patients with monoclonal IgD gammapathy. Biomedicine (1974) 0.76
Results of splenectomy for idiopathic thrombocytopenic purpura. Review of 72 cases. Acta Haematol (1993) 0.76
Dose-response studies of platelet aggregation and bleeding time during eicosapentaenoic acid intake. Thromb Haemost (1991) 0.76
Thrombomodulin is synthesized by osteoblasts, stimulated by 1,25-(OH)2D3 and activates protein C at their cell membrane. Endocrinology (1993) 0.76
Acute myocardial infarction: measurement of arachidonate end-products in whole blood as an index of platelet cyclo-oxygenase activity in vivo. Thromb Res (1987) 0.76
Functions and tocopherol content of blood platelets from elderly people after low intake of purified eicosapentaenoic acid. Thromb Res (1990) 0.76
[Waldenstrom's disease with terminal pulmonary alveolar proteinosis]. Lyon Med (1971) 0.76
Pharmacokinetic studies of standard heparin and low molecular weight heparin in patients with chronic renal failure. Haemostasis (1986) 0.76
Molecular study of Glanzmann thrombasthenia in 3 patients issued from 2 different families. Thromb Haemost (1995) 0.76
Efficacy and safety of continuous infusion of Mononine during five surgical procedures in three hemophilic patients. Am J Hematol (1998) 0.76
[Severe hemopathy and exposure to chlorine derivatives of benzene (apropos of 7 cases)]. J Med Lyon (1969) 0.76
[Calcium 47 absorption in alcoholic cirrhosis. Effect of 25 hydroxycholecalciferol]. Nouv Presse Med (1975) 0.75
Intravenous plasmin-treated gammaglobulin therapy in idiopathic thrombocytopenic purpura. Results in 40 patients. Nouv Rev Fr Hematol (1985) 0.75